Moderna Stock Jumps 7% Near 52-Week High Ahead of Nasdaq-100 Entry

Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?

Few large biotech stocks have rewarded patience like Moderna (NASDAQ:MRNA), and the size of that run now raises a hard question about what comes next. Moderna stock is up 545% year-to-date to $190.27, believe it or not. That figure leaves shareholders deciding whether to lock in their gains or lean further into the story. For […]

Moderna (NASDAQ:MRNA) Hits New 52-Week High - Time to Buy?

Moderna (NASDAQ:MRNA) Reaches New 1-Year High - Time to Buy?

Moderna Stock Jumps 7% Near 52-Week High Ahead of Nasdaq-100 Entry

Moderna Inc. (NASDAQ: MRNA) shares closed 6.95% higher at $203.21 on Monday as the vaccine maker approaches its scheduled addition to the Nasdaq-100 before Friday's market open.Visit Website